Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Operating Expenses: 2020-2025

Historic Operating Expenses for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to $64.3 million.

  • GeneDx Holdings' Operating Expenses rose 66.57% to $64.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $187.8 million, marking a year-over-year increase of 25.70%. This contributed to the annual value of $146.8 million for FY2024, which is 23.53% down from last year.
  • Latest data reveals that GeneDx Holdings reported Operating Expenses of $64.3 million as of Q3 2025, which was up 51.24% from $42.5 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Operating Expenses registered a high of $155.2 million during Q1 2021, and its lowest value of $24.8 million during Q2 2021.
  • For the 3-year period, GeneDx Holdings' Operating Expenses averaged around $44.6 million, with its median value being $40.4 million (2023).
  • Examining YoY changes over the last 5 years, GeneDx Holdings' Operating Expenses showed a top increase of 296.80% in 2022 and a maximum decrease of 56.17% in 2022.
  • Over the past 5 years, GeneDx Holdings' Operating Expenses (Quarterly) stood at $80.2 million in 2021, then declined by 15.74% to $67.6 million in 2022, then plummeted by 42.47% to $38.9 million in 2023, then decreased by 6.58% to $36.3 million in 2024, then skyrocketed by 66.57% to $64.3 million in 2025.
  • Its Operating Expenses stands at $64.3 million for Q3 2025, versus $42.5 million for Q2 2025 and $44.7 million for Q1 2025.